Literature DB >> 25104860

Understanding sickle cell brain drain.

Monica L Hulbert1, Andria L Ford1.   

Abstract

Mesh:

Year:  2014        PMID: 25104860      PMCID: PMC4126319          DOI: 10.1182/blood-2014-06-582403

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography.

Authors:  D R Powars; P S Conti; W Y Wong; P Groncy; C Hyman; E Smith; N Ewing; R N Keenan; C S Zee; Y Harold; A L Hiti; E L Teng; L S Chan
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

2.  Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease.

Authors:  W Reed; W Jagust; M Al-Mateen; E Vichinsky
Journal:  Am J Hematol       Date:  1999-04       Impact factor: 10.047

3.  Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.

Authors:  Benjamin C Kennedy; Michael M McDowell; Peter H Yang; Caroline M Wilson; Sida Li; Todd C Hankinson; Neil A Feldstein; Richard C E Anderson
Journal:  Neurosurg Focus       Date:  2014-01       Impact factor: 4.047

Review 4.  Cerebral hemodynamics in ischemic cerebrovascular disease.

Authors:  W J Powers
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

5.  Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler.

Authors:  R J Adams; V C McKie; E M Carl; F T Nichols; R Perry; K Brock; K McKie; R Figueroa; M Litaker; S Weiner; D Brambilla
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

6.  Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Authors:  Monica L Hulbert; Robert C McKinstry; JoAnne L Lacey; Christopher J Moran; Julie A Panepinto; Alexis A Thompson; Sharada A Sarnaik; Gerald M Woods; James F Casella; Baba Inusa; Jo Howard; Fenella J Kirkham; Kofi A Anie; Jonathan E Mullin; Rebecca Ichord; Michael Noetzel; Yan Yan; Mark Rodeghier; Michael R Debaun
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

7.  Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.

Authors:  Jon Detterich; Tamas Alexy; Miklos Rabai; Rosalinda Wenby; Ani Dongelyan; Thomas Coates; John Wood; Herbert Meiselman
Journal:  Transfusion       Date:  2012-08-06       Impact factor: 3.157

8.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

9.  Hemodynamic etiology of elevated flow velocity and stroke in sickle-cell disease.

Authors:  Isak Prohovnik; Anne Hurlet-Jensen; Robert Adams; Darryl De Vivo; Steven G Pavlakis
Journal:  J Cereb Blood Flow Metab       Date:  2009-02-11       Impact factor: 6.200

10.  Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.

Authors:  Kathleen J Helton; Robert J Adams; Karen L Kesler; Alex Lockhart; Banu Aygun; Catherine Driscoll; Matthew M Heeney; Sherron M Jackson; Lakshmanan Krishnamurti; Scott T Miller; Sharada A Sarnaik; William H Schultz; Russell E Ware
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

  10 in total
  7 in total

1.  Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.

Authors:  Erin M Hall; Jeffrey Leonard; Jodi L Smith; Kristin P Guilliams; Michael Binkley; Robert J Fallon; Monica L Hulbert
Journal:  Pediatr Blood Cancer       Date:  2016-04-22       Impact factor: 3.167

2.  Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting.

Authors:  Meher R Juttukonda; Manus J Donahue; Spencer L Waddle; Larry T Davis; Chelsea A Lee; Niral J Patel; Sumit Pruthi; Adetola A Kassim; Lori C Jordan
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-11       Impact factor: 6.200

3.  Noninvasive optical assessment of resting-state cerebral blood flow in children with sickle cell disease.

Authors:  Seung Yup Lee; Kyle R Cowdrick; Bharat Sanders; Eashani Sathialingam; Courtney E McCracken; Wilbur A Lam; Clinton H Joiner; Erin M Buckley
Journal:  Neurophotonics       Date:  2019-08-19       Impact factor: 3.593

Review 4.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

5.  Non-invasive imaging of oxygen extraction fraction in adults with sickle cell anaemia.

Authors:  Lori C Jordan; Melissa C Gindville; Allison O Scott; Meher R Juttukonda; Megan K Strother; Adetola A Kassim; Sheau-Chiann Chen; Hanzhang Lu; Sumit Pruthi; Yu Shyr; Manus J Donahue
Journal:  Brain       Date:  2016-01-27       Impact factor: 13.501

6.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

Review 7.  Stroke and presence of patent foramen ovale in sickle cell disease.

Authors:  Constantina Aggeli; Kali Polytarchou; Yannis Dimitroglou; Dimitrios Patsourakos; Sophia Delicou; Sophia Vassilopoulou; Eleftherios Tsiamis; Kostas Tsioufis
Journal:  J Thromb Thrombolysis       Date:  2021-02-26       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.